BackgroundCheck.run
Search For

Vernon W H Wong, 761905 Fordham Way, Mountain View, CA 94040

Known as:
Vernon Wong Wong Vernon W Wong Vernon Te Wong Vernon H Wong Vernon Wong Tte Dominique Patterson Linda Patterson Tte Vernon Wong
Related to:
Herbert V Wong Maggie Wang 30 Wai Wong 61 Brian Louie 47 Yu-Chi Liu Christopher Wong 56

Vernon Wong Phones & Addresses

1905 Fordham Way, Mountain View, CA 94040    650-9615770   

Loxley, AL   

Whitethorn, CA   

Chicago, IL   

Santa Clara, CA   

1905 Fordham Way, Mountain View, CA 94040   

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree
Get Report
Control this profile

Mentions for Vernon W H Wong

Career records & work history

Medicine Doctors

Vernon K. Wong

Specialties:
Ophthalmology
Work:
Wong & Wong Mds
1481 S King St STE 423, Honolulu, HI 96814
808-9429686 (phone)
Education:
Medical School
University of California, Los Angeles David Geffen School of Medicine
Graduated: 1990
Procedures:
Retinal Detachment Repair
Conditions:
Cataract, Glaucoma, Macular Degeneration
Languages:
English, Korean
Description:
Dr. Wong graduated from the University of California, Los Angeles David Geffen School of Medicine in 1990. He works in Honolulu, HI and specializes in Ophthalmology. Dr. Wong is affiliated with Kaiser Permanente Moanalua Medical Center and Queens Medical Center.

License Records

Vernon Joseph Wong Od

Licenses:
License #: 1236 - Expired
Category: Optometry
Issued Date: Apr 4, 2005
Effective Date: Aug 2, 2012
Expiration Date: Aug 1, 2012
Type: Optometrist

Vernon Joseph Wong Od

Licenses:
License #: 413 - Expired
Category: Optometry
Issued Date: Apr 4, 2005
Effective Date: Aug 2, 2012
Type: Therapeutic Certification

Vernon Wong resumes & CV records

Resumes

Vernon Wong Photo 22

Vernon Wong

Vernon Wong Photo 23

Vernon Wong

Publications & IP owners

Us Patents

Composition And Method For Treating Glaucoma

US Patent:
6369116, Apr 9, 2002
Filed:
Dec 23, 1998
Appl. No.:
09/221002
Inventors:
Vernon Wong - Menlo Park CA
Lin Peng - San Jose CA
Assignee:
Oculex Pharmaceuticals, Inc. - Sunnyvale CA
International Classification:
A01N 4338
US Classification:
514913, 424486, 424488
Abstract:
Implants and methods are provided for modulating wound healing and controlling infection to improve the success of glaucoma filtration surgery. Formulations of one or more therapeutically active agents and a biodegradable polymer provide a substantially constant rate of release for an extended period of time.

Method For Reducing Or Preventing Transplant Rejection In The Eye And Intraocular Implants For Use Therefor

US Patent:
6699493, Mar 2, 2004
Filed:
Nov 28, 2001
Appl. No.:
09/997094
Inventors:
Vernon G. Wong - Menlo Park CA
Assignee:
Oculex Pharmaceuticals, Inc. - Sunnyvale CA
International Classification:
A61F 214
US Classification:
424428, 5147723, 5147726, 514781
Abstract:
Methods for reducing or preventing transplant rejection in the eye of an individual are described, comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.

Methods For Treating Inflammation-Mediated Conditions Of The Eye

US Patent:
6726918, Apr 27, 2004
Filed:
Oct 20, 2000
Appl. No.:
09/693008
Inventors:
Vernon G. Wong - Menlo Park CA
Mae W. L. Hu - Los Altos Hills CA
Assignee:
Oculex Pharmaceuticals, Inc. - Sunnyvale CA
International Classification:
A61F 1300
US Classification:
424422, 424400, 424423, 424426, 424427, 424428, 424429
Abstract:
Methods for treating inflammation-mediated conditions of the eye are described, comprising: implanting into the vitreous of the eye of an individual a bioerodible implant comprising a steroidal anti-inflammatory agent and a bioerodible polymer, wherein the implant delivers the agent to the vitreous in an amount sufficient to reach a concentration equivalent to at least about 0. 05 g/ml dexamethasone within about 48 hours and maintains a concentration equivalent to at least about 0. 03 g/ml dexamethasone for at least about three weeks.

Methods For Reducing Or Preventing Transplant Rejection In The Eye And Intraocular Implants For Use Therefor

US Patent:
7033605, Apr 25, 2006
Filed:
Dec 22, 2003
Appl. No.:
10/744560
Inventors:
Vernon G. Wong - Menlo Park CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61F 2/14
US Classification:
424427, 424428
Abstract:
Methods for reducing or preventing transplant rejection in the eye of an individual are described, comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.

System And Method For Gas Flow Verification

US Patent:
7376520, May 20, 2008
Filed:
Mar 16, 2005
Appl. No.:
11/083761
Inventors:
Vernon Wong - Mountain View CA, US
Assignee:
Lam Research Corporation - Fremont CA
International Classification:
G01F 1/00
G01F 7/00
US Classification:
702 45, 73861
Abstract:
A gas flow rate verification apparatus is provided for shared use in a multiple tool semiconductor processing platform. The gas flow rate verification apparatus is defined to measure a pressure rate of rise and temperature within a test volume for determination of a corresponding gas flow rate. The apparatus includes first and second volumes, wherein the second volume is larger than the first volume. The apparatus also includes first and second pressure measurement devices, wherein the second pressure measurement device is capable of measuring higher pressures. Based on the target gas flow rate to be measured, either the first or second volume can be selected as the test volume, and either the first or second pressure measurement device can be selected to measure the pressure in the test volume. Configurability of the apparatus enables accurate measurement of gas flow rates over a broad range and in an time efficient manner.

Methods For Reducing Or Preventing Transplant Rejection In The Eye And Intraocular Implants For Use Therefor

US Patent:
7625582, Dec 1, 2009
Filed:
Apr 20, 2007
Appl. No.:
11/738409
Inventors:
Vernon G Wong - Menlo Park CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61F 2/02
US Classification:
424426
Abstract:
Methods for reducing or preventing transplant rejection in the eye of an individual are described, comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.

Methods For Reducing Or Preventing Transplant Rejection In The Eye And Intraocular Implants For Use

US Patent:
7767223, Aug 3, 2010
Filed:
Jul 11, 2005
Appl. No.:
11/180079
Inventors:
Vernon G. Wong - Menlo Park CA, US
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61F 2/14
US Classification:
424428
Abstract:
Methods for reducing or preventing transplant rejection in the eye of an individual are described, comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.

Methods For Performing Actual Flow Verification

US Patent:
7822570, Oct 26, 2010
Filed:
Nov 9, 2007
Appl. No.:
11/938171
Inventors:
Iqbal A. Shareef - Fremont CA, US
James V. Tietz - Fremont CA, US
Vernon Wong - Mountain View CA, US
Richard J. Meinecke - Fremont CA, US
Assignee:
Lam Research Corporation - Fremont CA
International Classification:
G01F 1/12
US Classification:
702100, 73 134
Abstract:
A method for determining an actual gas flow rate in a reaction chamber of a plasma processing system is provided. The method includes delivering gas by a gas flow delivery system controlled by a mass flow controller (MFC) to an orifice, which is located upstream from the reaction chamber. The method also includes pressurizing the gas to create a choked flow condition within the orifice. The method further includes measuring a set of upstream pressure values of the gas via a set of pressure sensors. The method yet also includes applying a calibration factor of a set of calibration factors to determine the actual flow rate. The calibration factor is a ratio of an average of the set of upstream pressure values to an average of a set of golden upstream pressure values, which is associated with an indicated flow rate for an MFC.

Possible Relatives

Cynthia W Wong  David K Wong  Cyrus L Wong  Davin R Wong  Davina H Wong  Dawson J Wong  Dean Wong  Vernon Johnson  Vernon M Stamps  Vernon E Johnston 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.